Routine haematology parameters in COVID-19 patients and clinical outcome: A Belgian single-centre study

Int J Lab Hematol. 2020 Dec;42(6):e252-e255. doi: 10.1111/ijlh.13313. Epub 2020 Sep 11.

Authors

Simke Demeester¹, Thomas Demuyser¹, Charlotte Fauconnier¹, Robbe Heestermans¹, Christelle Orlando¹, Barbara Depreter¹, Kristin Jochmans¹

Affiliation

¹ Department of Haematology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel, Brussels, Belgium.

PMID: 32915507
DOI: 10.1111/ijlh.13313

No abstract available

Keywords: COVID-19; erythroblast; outcome; prospective study; routine haematological parameters.

Publication types

Letter

MeSH terms

Aged
Belgium / epidemiology
Betacoronavirus*
Blood Cell Count*
Blood Coagulation Tests*
COVID-19
Coronavirus Infections / blood*
Coronavirus Infections / mortality
Diagnostic Tests, Routine
Female
Fibrin Fibrinogen Degradation Products / analysis*
Fibrinogen / analysis*
Humans
Male
Middle Aged
Pandemics
Pneumonia, Viral / blood*
Pneumonia, Viral / mortality
Prospective Studies
SARS-CoV-2
Treatment Outcome

Substances

Fibrin Fibrinogen Degradation Products
fibrin fragment D
Fibrinogen